This Solicitation opportunity from Department Of Defense was posted on May 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NALOXONE HYDROCHLOR

Closed

SPE2DP-26-T-3207Federal

Submission Closed05/11/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

Lidocaine Hydrochloride Jelly Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Orange Flavored Electrolyte Oral Hydration Powder

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5007

Solicitation SPE2DP-26-T-5007 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The requirement consists of three packages of oral pain relievers, each containing 16 lozenges with 15mg of Benzocaine and 2.6mg of Menthol, identified by NSN 6505-01-708-1449. The items must be stored between 20-25 degrees Celsius and protected from humidity, with a non-extendable shelf life of 36 months. Delivery is required within 20 days after order, with a required delivery date of September 14, 2026, shipped FOB Destination to Prince Sultan Air Base in Saudi Arabia. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, utilizing sealed unit containers to prevent damage. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contractor is required to use the Wide Area WorkFlow system for electronic invoicing and receiving reports. This procurement is governed by NAICS 325411 and includes standard FAR and DFARS clauses regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-5016

This contract is for the procurement of fruit punch flavored glucose gel, provided in 1.1oz squeezable pouches and sold in packages of six. The product is fat-free, gluten-free, and designed for energy boosting, with a non-extendable shelf life of 36 months. Storage requirements specify room temperature and prohibit refrigeration, freezing, or exposure to excessive heat and moisture. The order consists of four packages to be delivered to the Naval Health Clinic Quantico in Virginia within 20 days. Compliance is required for DLA packaging and palletization standards, as well as Medical Marking Standard No. 1. The shipment must be sent via traceable means, and the contract adheres to specific technical and quality requirements set forth in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-26-T-4991

Solicitation SPE2DP-26-T-4991, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotes for orange flavored electrolyte oral rehydration salts. The requirement consists of four packages of 21 gram packets, provided in quantities of 100 per unit, under NSN 6505-01-687-1441. The delivery is specified as FOB Destination with a required delivery date of September 11, 2026, and a delivery window of 20 days after the order. Inspection and acceptance will occur at the destination, specifically for shipment to the USS Tucson SSN 770. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4997

Solicitation SPE2DP-26-T-4997 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Lidocaine Hydrochloride 2% mucosal jelly. The requirement consists of two boxes of sterile topical anesthetic, with each box containing ten 11ml single-use prefilled plastic syringes, each providing 220 mg of the substance. The items are identified by NSN 6505-01-707-4169 and are subject to a non-extendable shelf-life requirement of 36 months. Delivery is required within 20 days after the order, with an original required delivery date of May 1, 2025. The shipping terms are FOB Destination, with primary delivery to Camp Pendleton, California, and a bulk break point in Palmerston, Australia. The contractor must adhere to strict packaging and marking standards, including MIL-STD-2073-1E, RP001 for palletization, and Medical Marking Standard No. 1. All items must be packaged in sealed unit containers to prevent damage and labeled according to the Hazard Communication Standard where applicable. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information. Quotations for this requirement were due by September 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPONSE

Solicitation # SPE2DS-26-T-421W

Solicitation SPE2DS-26-T-421W is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of eight Card Casualty Response Documentation Tools, identified by NSN 6515-01-575-2772. These tools are designed for first responders to document initial casualty treatment and consist of 6.5 by 4.25 inch card stock wrapped in clear plastic, featuring a grommet, a 14-inch cable tie for patient attachment, and a unique individual bar code identifier. The items must be delivered to Fort Bragg, North Carolina, within 20 days after receipt of the order, with a required delivery date of September 14, 2026. The contract mandates strict adherence to DLA Master List of Technical and Quality Requirements, ASTM D3951 for packaging, and MIL-STD-129 and Medical Marking Standard No. 1 for labeling. Bidders are required to specify the source and part number being supplied and must provide a complete data package for any alternate parts offered. Evaluation may include a HUBZone price preference. Compliance with the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information is required. Invoicing and payment must be processed through the Wide Area WorkFlow system, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4950

Contract SPE2DP-26-T-4950 is a solicitation issued by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of Psyllium Hydrophilic Mucilloid with sugar orange flavor. The item is supplied in 12 gram packets, with each packet containing 25 mg of potassium and 5 mg of sodium, provided in packages of 30. The requirement is for one package under NSN 6505017193181, with a specified shelf life of 24 months that is non-extendable. The product is regulated by the FDA and must be marked according to Medical Marking Standard No. 1. The contract specifies delivery to the USS Roosevelt DDG 80 within 20 days of order. All packaging and palletization must adhere to DLA packaging requirements for procurement and MIL-STD-2073-1E, ensuring items are in sealed unit containers to prevent damage. Bidders are required to specify the source and part number, with the reference part number listed as NDC37000-0740-87 from Procter and Gamble Distributing LLC. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4946

Contract SPE2DP-26-T-4946 is a solicitation issued by the Department of Defense, specifically the DLA Troop Support Medical Supply Chain Pharm FSA, for the procurement of Ondansetron Injection, USP. The requirement is for a 2 mg/ml concentration in 2ml single dose vials, with a package size of 25 units per package. The item must have a non-extendable shelf life of 24 months and be stored between 2 and 25 degrees Celsius while being protected from light. Approved part numbers include those from Hikma Pharmaceuticals USA Inc, Pfizer Inc, and American Pharmaceutical Partners. The contract specifies a quantity of one package under NSN 6505015786170, with a required delivery date of July 2, 2025, and a delivery window of 20 days after order. Shipping is FOB destination to the 5th BN 14th Marines in Seal Beach, California, and must be sent via traceable means rather than parcel post. Packaging must adhere to commercial standards, Medical Marking Standard No. 1, and DLA packaging requirements for procurement. The solicitation falls under NAICS code 325411 and requires compliance with the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

High Char Yield Polymer Resin Development

NASA SBIR/STTR Program

POSTED

DEADLINE

Supplier of Raw Active Pharmaceutical Ingredient (API) – DiazepamThe Defense Logistics Agency, under the Department of Defense, has established a subcontract for the supply of bulk Diazepam Active Pharmaceutical Ingredient. The material must adhere to USP standards to ensure suitability for the formulation of 5 mg tablets. The supplier is required to provide a Certificate of Analysis and necessary regulatory support to maintain compliance. This procurement falls under NAICS code 325411 and was posted on August 11, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Active Pharmaceutical Ingredient (API) – Promethazine HydrochlorideThe contract pertains to the supply of USP-grade promethazine hydrochloride active pharmaceutical ingredient for use in the final formulation of a pharmaceutical product, specifically under a subcontract arrangement. The procurement is managed by the Defense Logistics Agency within the Department of Defense, with the NAICS code 325411 indicating classification under pharmaceutical and biological product manufacturing. Although the solicitation number and specific point of contact are not provided, the posting date is August 9, 2026, and the performance location details are unspecified. The API must meet United States Pharmacopeia standards to ensure quality and compliance with regulatory requirements for drug manufacturing. The contract reference number SPE2DX25D8022 and delivery identifier SPE2D926F8075 are linked through the DIBBS system, facilitating tracking and award administration for the supplier.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

The contract is for the procurement of Naloxone Hydrochloride Intranasal Spray, 4 mg per single-dose nasal spray, provided in two-unit blister packs, with each spray device containing 0.1 mL of solution. The product must be stored at room temperature or refrigerated between 2 to 25 degrees Celsius (36 to 77 degrees Fahrenheit) and must not be frozen or exposed to excessive heat above 40 degrees Celsius (104 degrees Fahrenheit). Each box contains two units, and the item has a non-extendable shelf life of 36 months. Packaging must comply with commercial standards as specified in the procurement documentation, with each unit sealed in protective containers to prevent damage, and all shipments must use suitable exterior containers that ensure safe, cost-effective delivery via common carriers. Marking must follow Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging and palletization adheres to DLA requirements. The item is regulated by the FDA and requires prior confirmation by a product specialist before procurement. The manufacturer is Emergent Devices, Inc., with NDC 69547-0627-02, and the NSN is 6505017142921. Two boxes are required, totaling four individual sprays, with delivery due within 20 days to Fort Bragg, North Carolina, FOB destination, no tolerance for quantity variance, and inspection and acceptance occurring at the delivery point. Shipment must be traceable, excluding parcel post, and includes specific military identifying codes and project identifiers for government tracking. The solicitation was issued with a response deadline of May 11, 2026, under contract number SPE2DP-26-T-3207.

General Info

Procurement of 4 mg Naloxone intranasal spray, 4 units, FDA-regulated, delivered within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3207.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedMay 3

Solicitation

Response DeadlineMay 11

Deadline has passed

Submission Closed

05/11/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

DANIEL PORTER

contact@example.gov

+1 (555) 000-0000

Full Description

NALOXONE HYDROCHLOR
NALOXONE HYDROCHLORIDE INTRANASAL SPRAY
4MG NASAL SPRAY 2 SINGLE-DOSE NASAL SPRAY
DEVICES 0.003 FL OZ (0.1 ML) EACH.
.
STORE AT ROOM TEMPERATURE OR REFRIGERATED BETWEEN
2 TO 25 DEGREES C OR 36 TO 77 DEGREES F. DO NOT
FREEZE. AVOID EXCESSIVE HEAT ABOVE 40 DEGREES C
OR 104 DEGREES F.
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
1 BX = 2 EA . APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3207
SECTION B
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
EMERGENT DEVICES, INC. 7ARJ9 P/N NDC69547-0627-02
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016584429 0001 BX 2.000
NSN/MATERIAL:6505017142921
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
STORE AT ROOM TEMPERATURE OR REFRIGERATED BETWEEN 2 TO 25 DEGREES C OR 36 TO 77 DEGREES F. DO NOT FREEZE. AVOID EXCESSIVE HEAT ABOVE 40 DEGREES C OR 104 DEGREES F.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
SPE2DP-26-T-3207
SECTION B
PR: 7016584429 PRLI: 0001 CONT’D
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
MARKFOR
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
M/F: (TCN) W8002S61190226
RDD: 133
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/04/2026
SPE2DP-26-T-3207 NSN/Part Number: 6505-01-714-2921 Quantity: 2 BX Purchase Request: 7016584429QTY: 2 Delivery: 20 days ADO